benefits of microdosing glp-1 Let's talk about “microdosing” GLP-1s — because this trend needs to stop. This idea didn't come from science. It came from inexperienced prescribers who saw patients experiencing side effects at therapeutic doses — What Is Microdosing GLP-1s, and

Ongoing research hints at benefits for cognitive health, particularly in neurodegenerative diseases like Alzheimers, as GLP-1 has anti-inflammatory and neuroprotective properties, Dr

These benefits were subsequently confirmed in well-powered studies specifically designed to evaluate kidney outcomes [1, 2]

The FDA drug list they reference

This is not a close comparison

Although most side effects are manageable, there are some rare but serious risks

Several methods are introduced to increase the half-life of GLP-1 including: (i) modifying peptides to make them resistant to cleavage by DPP-4, such as exenatide twice daily and lixisenatide, (ii) attaching free fatty acid side chains to liraglutide and semaglutide, which enhances their binding to plasma albumin thereby preventing renal filtration of GLP-1 and prolonging their action in vivo [36, 37], (iii) conjugation of albumin or the Fc fragment of IgG to GLP-1 molecule is used in albiglutide and dulaglutide [37, 38], (iv) development of modified nanoparticles for the controlled release of exenatide-LAR (long-acting release) that provide prolonged release of the peptide [39], and finally, (v) chemical permeation enhancers such as sodium salcaprozate (SNAC) could be utilized to overcome the low permeability and high enzymatic degradation of the gastrointestinal tract of GLP-1 analog that is administrated orally such as semaglutide [40]